Literature DB >> 17853466

Studies of age-correlated features of cognitive-behavioral development in children and adolescents with genetic disorders.

Gene S Fisch1, Nancy Carpenter, Patricia N Howard-Peebles, Jeanette J A Holden, Jack Tarleton, Richard Simensen, Walter Nance.   

Abstract

Studies of age-related features of cognitive-behavioral deficits produced by genetic mutations permit us to draw inferences about how brain development may be related cognitive ability as the child ages. Except for Down syndrome (DS) and the fragile X mutation (FRAXA), little is known about the longitudinal changes in cognitive-behavioral development in individuals with genetic abnormalities producing learning disabilities (LD) or mental retardation (MR). The purpose of this prospective study was to compare and contrast age related to cognitive abilities, adaptive and maladaptive behaviors in children and adolescents in the same age range, diagnosed with one of three genetic disorders: the FRAXA mutation, Neurofibromatosis type 1 (NF1) or Williams-Beuren syndrome (WBS). We also sought to examine whether cognitive-behavioral abilities associated with these three genetic disorders were related systematically to age. We examined 108 children, ages 4-15 years, with FRAXA, WBS, or NF1. Results show that there is a significant negative correlation between age and IQ, and between age and adaptive behavior (DQ) scores, in children with FRAXA and WBS, but not in children with NF1. All three groups of children have unusually high proportions of maladaptive behavior, ranging from 1/6 children with NF1 to 2/3 children with FRAXA. Cognitive and adaptive behavior profiles of children with FRAXA and WBS were also surprisingly similar. Our findings suggest the need for examining longitudinal developmental cognitive-behavioral changes in children and adolescents with all genetic disorders that produce LD or MR. Copyright (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17853466     DOI: 10.1002/ajmg.a.31915

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  13 in total

Review 1.  Public Health Literature Review of Fragile X Syndrome.

Authors:  Melissa Raspa; Anne C Wheeler; Catharine Riley
Journal:  Pediatrics       Date:  2017-06       Impact factor: 7.124

2.  Effects of germline mutations in the Ras/MAPK signaling pathway on adaptive behavior: cardiofaciocutaneous syndrome and Noonan syndrome.

Authors:  Elizabeth I Pierpont; Mary Ella Pierpont; Nancy J Mendelsohn; Amy E Roberts; Erica Tworog-Dube; Katherine A Rauen; Mark S Seidenberg
Journal:  Am J Med Genet A       Date:  2010-03       Impact factor: 2.802

3.  Autonomic regulation in fragile X syndrome.

Authors:  Keri J Heilman; Emily R Harden; Danielle M Zageris; Elizabeth Berry-Kravis; Stephen W Porges
Journal:  Dev Psychobiol       Date:  2011-05-05       Impact factor: 3.038

4.  Adaptive behavior in infants and toddlers with Down syndrome and fragile X syndrome.

Authors:  Elizabeth A Will; Kelly E Caravella; Laura J Hahn; Deborah J Fidler; Jane E Roberts
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2018-02-05       Impact factor: 3.568

5.  Viewing social scenes: a visual scan-path study comparing fragile X syndrome and Williams syndrome.

Authors:  Tracey A Williams; Melanie A Porter; Robyn Langdon
Journal:  J Autism Dev Disord       Date:  2013-08

6.  Do Children With Fragile X Syndrome Show Declines or Plateaus in Adaptive Behavior?

Authors:  Laura J Hahn; Nancy C Brady; Steven F Warren; Kandace K Fleming
Journal:  Am J Intellect Dev Disabil       Date:  2015-09

7.  Longitudinal profiles of adaptive behavior in fragile X syndrome.

Authors:  Cheryl Klaiman; Eve-Marie Quintin; Booil Jo; Amy A Lightbody; Heather Cody Hazlett; Joseph Piven; Scott S Hall; Lindsay C Chromik; Allan L Reiss
Journal:  Pediatrics       Date:  2014-08       Impact factor: 7.124

8.  A neurodevelopmental perspective on the acquisition of nonverbal cognitive skills in adolescents with fragile X syndrome.

Authors:  Sara T Kover; Elizabeth I Pierpont; Jee-Seon Kim; W Ted Brown; Leonard Abbeduto
Journal:  Dev Neuropsychol       Date:  2013       Impact factor: 2.253

9.  Neurofibromatosis type 1 and the "elephant man's" disease: the confusion persists: an ethnographic study.

Authors:  Claire-Marie Legendre; Catherine Charpentier-Côté; Régen Drouin; Chantal Bouffard
Journal:  PLoS One       Date:  2011-02-09       Impact factor: 3.240

10.  Long-term follow-up and treatment in nine boys with X-linked creatine transporter defect.

Authors:  Jiddeke M van de Kamp; Petra J W Pouwels; Femke K Aarsen; Leontine W ten Hoopen; Dirk L Knol; Johannes B de Klerk; Ireneus F de Coo; Jan G M Huijmans; Cornelis Jakobs; Marjo S van der Knaap; Gajja S Salomons; Grazia M S Mancini
Journal:  J Inherit Metab Dis       Date:  2011-05-10       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.